# Principal Financial Group Inc: financial statements, quarterly

PFG · Nasdaq · CIK 1126328 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pfg.md) · [Financials](/companies/pfg/financials.md) · [Filings](/companies/pfg/filings.md) · [Insiders](/companies/pfg/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pfg/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,691 d](/filings/0001104659-26-017031.md) | [4,053](/filings/0001410578-25-001036.md) | [4,311](/filings/0001410578-25-001534.md) | [3,012](/filings/0001104659-25-103708.md) | [4,752 d](/filings/0001104659-26-017031.md) | [3,696](/filings/0001104659-26-051384.md) | [3,671](/filings/0001104659-26-088071.md) | [3,682](/filings/0001104659-26-120103.md) | [4,577 d](/filings/0001104659-26-017031.md) | [3,529](/filings/0001104659-26-051384.md) | [3,906](/filings/0001104659-26-088071.md) | [4,616](/filings/0001104659-26-120103.md) |
| Income tax | $m | [(268) d](/filings/0001104659-26-017031.md) | [95.1](/filings/0001410578-25-001036.md) | [87.1](/filings/0001410578-25-001534.md) | [(100)](/filings/0001104659-25-103708.md) | [210 d](/filings/0001104659-26-017031.md) | [(34.0)](/filings/0001104659-26-051384.md) | [69.6](/filings/0001104659-26-088071.md) | [14.5](/filings/0001104659-26-120103.md) | [110 d](/filings/0001104659-26-017031.md) | [68.9](/filings/0001104659-26-051384.md) | [66.0](/filings/0001104659-26-088071.md) | [242](/filings/0001104659-26-120103.md) |
| Net income | $m | [(872) d](/filings/0001104659-26-017031.md) | [533](/filings/0001410578-25-001036.md) | [353](/filings/0001410578-25-001534.md) | [(220)](/filings/0001104659-25-103708.md) | [905 d](/filings/0001104659-26-017031.md) | [48.1](/filings/0001104659-26-051384.md) | [406](/filings/0001104659-26-088071.md) | [214](/filings/0001104659-26-120103.md) | [517 d](/filings/0001104659-26-017031.md) | [425](/filings/0001104659-26-051384.md) | [403](/filings/0001104659-26-088071.md) | [632](/filings/0001104659-26-120103.md) |
| Diluted EPS | $ per share | not reported | [2.22](/filings/0001410578-25-001036.md) | [1.49](/filings/0001410578-25-001534.md) | [(0.95)](/filings/0001104659-25-103708.md) | not reported | [0.21](/filings/0001104659-26-051384.md) | [1.79](/filings/0001104659-26-088071.md) | [0.95](/filings/0001104659-26-120103.md) | not reported | [1.93](/filings/0001104659-26-051384.md) | [1.84](/filings/0001104659-26-088071.md) | [2.91](/filings/0001104659-26-120103.md) |
| Basic EPS | $ per share | not reported | [2.26](/filings/0001410578-25-001036.md) | [1.51](/filings/0001410578-25-001534.md) | [(0.95)](/filings/0001104659-25-103708.md) | not reported | [0.21](/filings/0001104659-26-051384.md) | [1.81](/filings/0001104659-26-088071.md) | [0.96](/filings/0001104659-26-120103.md) | not reported | [1.96](/filings/0001104659-26-051384.md) | [1.87](/filings/0001104659-26-088071.md) | [2.95](/filings/0001104659-26-120103.md) |

- Revenue: us-gaap:Revenues
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [4.7](/filings/0001410578-25-000160.md) | [4.2](/filings/0001410578-24-000583.md) | [4.8](/filings/0001410578-24-001133.md) | [6.2](/filings/0001410578-24-001713.md) | [4.2](/filings/0001104659-26-017031.md) | [3.9](/filings/0001410578-25-001036.md) | [3.7](/filings/0001410578-25-001534.md) | [5.1](/filings/0001104659-25-103708.md) | [4.4](/filings/0001104659-26-120103.md) | [4.1](/filings/0001104659-26-051384.md) | [5.3](/filings/0001104659-26-088071.md) | [4.5](/filings/0001104659-26-120103.md) |
| Total assets | $bn | [305](/filings/0001410578-25-000160.md) | [309](/filings/0001410578-24-000583.md) | [309](/filings/0001410578-24-001133.md) | [323](/filings/0001410578-24-001713.md) | [314](/filings/0001104659-26-017031.md) | [313](/filings/0001410578-25-001036.md) | [323](/filings/0001410578-25-001534.md) | [334](/filings/0001104659-25-103708.md) | [341](/filings/0001104659-26-120103.md) | [333](/filings/0001104659-26-051384.md) | [353](/filings/0001104659-26-088071.md) | [339](/filings/0001104659-26-120103.md) |
| Total liabilities | $bn | [294](/filings/0001410578-25-000160.md) | [297](/filings/0001410578-24-000583.md) | [297](/filings/0001410578-24-001133.md) | [311](/filings/0001410578-24-001713.md) | [302](/filings/0001104659-26-017031.md) | [301](/filings/0001410578-25-001036.md) | [311](/filings/0001410578-25-001534.md) | [322](/filings/0001104659-25-103708.md) | [329](/filings/0001104659-26-120103.md) | [320](/filings/0001104659-26-051384.md) | [340](/filings/0001104659-26-088071.md) | [326](/filings/0001104659-26-120103.md) |
| Long-term debt | $bn | [3.9](/filings/0001410578-25-000160.md) | [3.9](/filings/0001410578-24-000583.md) | [3.9](/filings/0001410578-24-001133.md) | [3.9](/filings/0001410578-24-001713.md) | [4.0](/filings/0001104659-26-017031.md) | [4.3](/filings/0001410578-25-001036.md) | [3.9](/filings/0001410578-25-001534.md) | [3.9](/filings/0001104659-25-103708.md) | [3.9](/filings/0001104659-26-120103.md) | [3.9](/filings/0001104659-26-051384.md) | [4.3](/filings/0001104659-26-088071.md) | [4.3](/filings/0001104659-26-120103.md) |
| Short-term borrowings | $bn | [0.1](/filings/0001410578-25-000160.md) | [0.1](/filings/0001410578-24-000583.md) | [0.0](/filings/0001410578-24-001133.md) | [0.0](/filings/0001410578-24-001713.md) | [0.2](/filings/0001104659-26-017031.md) | [0.0](/filings/0001410578-25-001036.md) | [0.0](/filings/0001410578-25-001534.md) | [0.0](/filings/0001104659-25-103708.md) | [0.0](/filings/0001104659-26-120103.md) | [0.0](/filings/0001104659-26-051384.md) | [0.0](/filings/0001104659-26-088071.md) | [0.2](/filings/0001104659-26-120103.md) |
| Shareholders' equity | $bn | [10.9](/filings/0001410578-25-000160.md) | [11.2](/filings/0001410578-24-000583.md) | [11.0](/filings/0001410578-24-001133.md) | [11.2](/filings/0001410578-24-001713.md) | [11.1](/filings/0001104659-26-017031.md) | [11.2](/filings/0001410578-25-001036.md) | [11.4](/filings/0001410578-25-001534.md) | [11.7](/filings/0001104659-25-103708.md) | [11.9](/filings/0001104659-26-120103.md) | [11.8](/filings/0001104659-26-051384.md) | [12.1](/filings/0001104659-26-088071.md) | [11.8](/filings/0001104659-26-120103.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [944 d](/filings/0001104659-26-017031.md) | [584](/filings/0001410578-25-001036.md) | [1,432 d](/filings/0001410578-25-001534.md) | [1,128 d](/filings/0001104659-25-103708.md) | [1,459 d](/filings/0001104659-26-017031.md) | [977](/filings/0001104659-26-051384.md) | [812 d](/filings/0001104659-26-088071.md) | [1,004 d](/filings/0001104659-26-120103.md) | [1,744 d](/filings/0001104659-26-017031.md) | [187](/filings/0001104659-26-051384.md) | [2,077 d](/filings/0001104659-26-088071.md) | [1,527 d](/filings/0001104659-26-120103.md) |
| Dividends paid | $m | [159 d](/filings/0001104659-26-017031.md) | [162](/filings/0001410578-25-001036.md) | [165 d](/filings/0001410578-25-001534.md) | [165 d](/filings/0001104659-25-103708.md) | [166 d](/filings/0001104659-26-017031.md) | [169](/filings/0001104659-26-051384.md) | [170 d](/filings/0001104659-26-088071.md) | [173 d](/filings/0001104659-26-120103.md) | [172 d](/filings/0001104659-26-017031.md) | [174](/filings/0001104659-26-051384.md) | [177 d](/filings/0001104659-26-088071.md) | [179 d](/filings/0001104659-26-120103.md) |
| Share repurchases | $m | [251 d](/filings/0001104659-26-017031.md) | [234](/filings/0001410578-25-001036.md) | [250 d](/filings/0001410578-25-001534.md) | [252 d](/filings/0001104659-25-103708.md) | [306 d](/filings/0001104659-26-017031.md) | [240](/filings/0001104659-26-051384.md) | [159 d](/filings/0001104659-26-088071.md) | [228 d](/filings/0001104659-26-120103.md) | [275 d](/filings/0001104659-26-017031.md) | [235](/filings/0001104659-26-051384.md) | [258 d](/filings/0001104659-26-088071.md) | [251 d](/filings/0001104659-26-120103.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [243](/filings/0001410578-24-000583.md) | [246](/filings/0001410578-24-001133.md) | [244](/filings/0001410578-24-001713.md) | [239](/filings/0001410578-25-001036.md) | [237](/filings/0001410578-25-001534.md) | [231](/filings/0001104659-25-103708.md) | [229](/filings/0001104659-26-051384.md) | [227](/filings/0001104659-26-088071.md) | [225](/filings/0001104659-26-120103.md) | [220](/filings/0001104659-26-051384.md) | [219](/filings/0001104659-26-088071.md) | [217](/filings/0001104659-26-120103.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 212,376,467 at 2026-10-22, from the cover of the [10-Q filed 2026-10-29](/filings/0001104659-26-120103.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 14:19 ET. No prices; not investment advice.